WHO recommends long-lasting cabotegravir for HIV prevention

News Release by World Health Organization  WHO on 28/07/22 released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention option for people at substantial risk of